TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/18/24 17:31 | 11/14/24 | DYN | Dyne Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rhodes Jason P | MA | D | S | -26 | 33.10 | 0 | -1 | 0 | 847 | I | |||||||||||||||
3/5/24 17:08 | 3/1/24 | DYN | Dyne Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rhodes Jason P | MA | D | S | -1,398 | 30.05 | 0 | -47 | -1 | 6,545 | I | |||||||||||||||
2/28/24 19:15 | 2/26/24 | DYN | Dyne Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rhodes Jason P | MA | D | S.m | -19,627 | 24.30 | 0 | -808 | -48 | 864 | I | |||||||||||||||
2/23/24 18:59 | 2/21/24 | DYN | Dyne Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rhodes Jason P | MA | D | S.m | -11,340 | 22.64 | 0 | -501 | -35 | 921 | I | |||||||||||||||
2/20/24 18:36 | 2/15/24 | DYN | Dyne Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rhodes Jason P | MA | D | S.m | -11,867 | 23.26 | 0 | -510 | -5 | 9,359 | I | |||||||||||||||
12/14/22 16:56 | 12/12/22 | DYN | Dyne Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rhodes Jason P | MA | D | P | 10,000 | 10.70 | 0 | 935 | 10 | 9,869 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |